# BioHybrid Solutions wins $30M DoD contract for nerve agent countermeasures

BioHybrid Solutions, based in Harmar, Pennsylvania, has been awarded a $30 million contract by the U.S. Department of Defense to develop countermeasures for chemical agents such as sarin gas. The contract will last for five years.

- Type: Contract
- Announced: 2019-12-06
- Where: Harmar, Pennsylvania, United States
- Value: $30.0M
- Status: announced
- Products: nerve agent countermeasures
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [BioHybrid Solutions](https://endata.com/companies/43790.md)
- [U.S. Department of Defense](https://endata.com/companies/4836.md) (customer)

## Sources

- [witf.org](https://www.witf.org/2019/12/06/department-of-defense-contracts-pa-biotech-company-to-make-meds-to-counter-nerve-agents/), 2019-12-06: "The $30 million contract will last for five years."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.